Fecal Microbiota Transplant to Treat Recurrent Clostridium difficile Infections | Citedby Results | Critical Care Nurse | American Association of Critical-Care Nurses

Skip to Main Content

Skip Nav Destination

Fecal Microbiota Transplant to Treat Recurrent Clostridium difficile Infections

Crit Care Nurse (2015) 35 (2): 51–64.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Host-defense piscidin peptides as antibiotic adjuvants against Clostridioides difficile

Adenrele Oludiran
Areej Malik
Andriana C. Zourou
Yonghan Wu
Steven P. Gross
Albert Siryapon
Asia Poudel
Kwincy Alleyne
Savion Adams
David S. Courson
Myriam L. Cotten
Erin B. Purcell
Muhammad Yasir

PLOS ONE (2024) 19 (1): e0295627.

FEKAL MİKROBİYOTA TRANSPLANTASYONU VE HEMŞİRELİK

Gülistan YOLDAŞ
Aynur TÜREYEN

Journal of Anatolia Nursing and Health Sciences 534.

The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile

Astha Pokhrel
Asia Poudel
Kory B. Castro
Michael J. Celestine
Adenrele Oludiran
Alden J. Rinehold
Anthony M. Resek
Mariam A. Mhanna
Erin B. Purcell
Michael J. Federle

Journal of Bacteriology (2020) 202 (19)

Determinación de la microbiota intestinal en pacientes cirróticos de población mestizo-mexicana

C. Pérez-Monter
I. Escalona-Nandez
A. Estanes-Hernández
L.G. Noriega-López
A. Torre-Delgadillo

Revista de Gastroenterología de México (2019) 84 (1): 26.

Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population

C. Pérez-Monter
I. Escalona-Nandez
A. Estanes-Hernández
L.G. Noriega-López
A. Torre-Delgadillo

Revista de Gastroenterología de México (English Edition) (2019) 84 (1): 26.

How Oxygen Availability Affects the Antimicrobial Efficacy of Host Defense Peptides: Lessons Learned from Studying the Copper-Binding Peptides Piscidins 1 and 3

Adenrele Oludiran
David S. Courson
Malia D. Stuart
Anwar R. Radwan
John C. Poutsma
Myriam L. Cotten
Erin B. Purcell

International Journal of Molecular Sciences (2019) 20 (21): 5289.

Clostridium difficile

Shelley C. Moore

Critical Care Nursing Clinics of North America (2018) 30 (1): 41.

Fecal microbiota transplantation in recurrent Clostridium difficile infection: the first prospective study of 30 patients in Romania

Laszlo Mihaela
Oliviu Pascu
Daniel-Corneliu Leucuta
Vasile Andreica

Revista Romana de Medicina de Laborator (2018) 26 (2): 201.

Evidence-Based Practice in the Treatment for Antibiotic-Associated Diarrhea in the Intensive Care Unit

Robin Squellati

Critical Care Nursing Clinics of North America (2018) 30 (1): 87.

Dissemination ofClostridium difficilein food and the environment: Significant sources ofC. difficilecommunity-acquired infection?

K. Warriner
C. Xu
M. Habash
S. Sultan
S.J. Weese

Journal of Applied Microbiology (2017) 122 (3): 542.

Pathogenesis of NEC: Impact of an altered intestinal microbiome

Josef Neu
Mohan Pammi

Seminars in Perinatology (2017) 41 (1): 29.

Fecal microbiota transplantation in recurrent C. difficile infection

Margaret Harvey Granitto
Colleen Krebs Norton

Nursing Critical Care (2016) 11 (1): 25.

Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue?

Mark Stuntz
Franka des Vignes

Contemporary Clinical Trials Communications (2015) 1: 39.